RecruitingNot applicableNCT04781790
French National Registry of Bone Marrow Failures
Studying Autosomal dominant aplasia and myelodysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Régis Peffault De Latour
- Intervention
- Bone Marrow Failure(other)
- Enrollment
- 5000 enrolled
- Eligibility
- All sexes
- Timeline
- 2017 – 2027
Study locations (1)
- Hématologie Greffe, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04781790 on ClinicalTrials.govOther trials for Autosomal dominant aplasia and myelodysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06090669Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 DeficiencyNational Cancer Institute (NCI)
- RECRUITINGNANCT02958462Pre-myeloid Cancer and Bone Marrow Failure Clinic StudyMayo Clinic
- RECRUITINGNCT01905826Natural History Study of GATA2 Deficiency and Related DisordersNational Institute of Allergy and Infectious Diseases (NIAID)
See all trials for Autosomal dominant aplasia and myelodysplasia →